返回
LI-RADS: Looking Back, Looking Forward
DOI:10.1148/radiol.222801.png)
摘要
En 中文
Since its initial release in 2011, the Liver Imaging Reporting and Data System (LI-RADS) has evolved and expanded in scope. It started as a single algorithm for hepatocellular carcinoma (HCC) diagnosis with CT or MRI with extracellular contrast agents and has grown into a multialgorithm network covering all major liver imaging modalities and contexts of use. Furthermore, it has de-veloped its own lexicon, report templates, and supplementary materials. This article highlights the major achievements of LI-RADS in the past 11 years, including adoption in clinical care and research across the globe, and complete unification of HCC diagnostic systems in the United States. Additionally, the authors discuss current gaps in knowledge, which include challenges in surveil-lance, diagnostic population definition, perceived complexity, limited sensitivity of LR-5 (definite HCC) category, management implications of indeterminate observations, challenges in reporting, and treatment response assessment following radiation-based therapies and systemic treatments. Finally, the authors discuss future directions, which will focus on mitigating the current chal-lenges and incorporating advanced technologies. Tha authors envision that LI-RADS will ultimately transform into a probability -based system for diagnosis and prognostication of liver cancers that will integrate patient characteristics and quantitative imaging features, while accounting for imaging modality and contrast agent.(c) RSNA, 2023
Keyword:
ACID-ENHANCED MRI
HYPERVASCULAR HYPOINTENSE NODULES
LONG-TERM OUTCOMES
HEPATOCELLULAR-CARCINOMA
HEPATOBILIARY PHASE
MAGNETIC-RESONANCE
NONINVASIVE DIAGNOSIS
ANCILLARY FEATURES
T2 HYPERINTENSITY
VERSION 2018
期刊
IF:
15.2
论文数:
4.0W
被引数:
6.0W
机构
引用论文
Simultaneous control of propulsion and levitation of linear induction motor in a novel Maglev system
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases肝细胞癌的诊断,分期和管理: 美国肝病研究协会的2018实践指导
HEPATOLOGY
IF15.8
Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience通过使用li-rads和辅助特征的超声造影在肝细胞癌中的作用: 单个三级中心的经验
DIAGNOSTICS
IF3.3

